| Programmed death ligand-1 over-expression correlates with malignancy and contributes to immune regulation in ovarian cancer CJ Maine, NHA Aziz, J Chatterjee, C Hayford, N Brewig, L Whilding, ... Cancer immunology, immunotherapy 63, 215-224, 2014 | 152 | 2014 |
| PTPN22 alters the development of regulatory T cells in the thymus CJ Maine, EE Hamilton-Williams, J Cheung, SM Stanford, N Bottini, ... The Journal of Immunology 188 (11), 5267-5275, 2012 | 129 | 2012 |
| A miR-155–Peli1–c-Rel pathway controls the generation and function of T follicular helper cells WH Liu, SG Kang, Z Huang, CJ Wu, HY Jin, CJ Maine, Y Liu, J Shepherd, ... Journal of Experimental Medicine 213 (9), 1901-1919, 2016 | 75 | 2016 |
| PTPN22 controls the germinal center by influencing the numbers and activity of T follicular helper cells CJ Maine, K Marquardt, J Cheung, LA Sherman The Journal of Immunology 192 (4), 1415-1424, 2014 | 72 | 2014 |
| Clinical use of programmed cell death-1 and its ligand expression as discriminatory and predictive markers in ovarian cancer J Chatterjee, W Dai, NHA Aziz, PY Teo, J Wahba, DL Phelps, CJ Maine, ... Clinical Cancer Research 23 (13), 3453-3460, 2017 | 65 | 2017 |
| The adaptor protein TRAF3 inhibits interleukin-6 receptor signaling in B cells to limit plasma cell development WW Lin, Z Yi, LL Stunz, CJ Maine, LA Sherman, GA Bishop Science signaling 8 (392), ra88-ra88, 2015 | 48 | 2015 |
| CRISPR-Cas9–Mediated Modification of the NOD Mouse Genome With Ptpn22R619W Mutation Increases Autoimmune Diabetes X Lin, S Pelletier, S Gingras, S Rigaud, CJ Maine, K Marquardt, YD Dai, ... Diabetes 65 (8), 2134-2138, 2016 | 42 | 2016 |
| PTPN22 contributes to exhaustion of T lymphocytes during chronic viral infection CJ Maine, JR Teijaro, K Marquardt, LA Sherman Proceedings of the National Academy of Sciences 113 (46), E7231-E7239, 2016 | 40 | 2016 |
| Autoimmunity-associated LYP-W620 does not impair thymic negative selection of autoreactive T cells DJ Wu, W Zhou, S Enouz, V Orru, SM Stanford, CJ Maine, N Rapini, ... PLoS One 9 (2), e86677, 2014 | 33 | 2014 |
| The effect of the autoimmunity-associated gene, PTPN22, on a BXSB-derived model of lupus CJ Maine, K Marquardt, JC Scatizzi, KM Pollard, DH Kono, LA Sherman Clinical Immunology 156 (1), 65-73, 2015 | 20 | 2015 |
| Self-replicating RNAs drive protective anti-tumor T cell responses to neoantigen vaccine targets in a combinatorial approach CJ Maine, G Richard, DS Spasova, SJ Miyake-Stoner, J Sparks, L Moise, ... Molecular Therapy 29 (3), 1186-1198, 2021 | 16 | 2021 |
| Ptpn22 and Cd2 variations are associated with altered protein expression and susceptibility to type 1 diabetes in nonobese diabetic mice HI Fraser, S Howlett, J Clark, DB Rainbow, SM Stanford, DJ Wu, ... The Journal of Immunology 195 (10), 4841-4852, 2015 | 12 | 2015 |
| Rna replicon vaccines against hbv JL DeHart, NS Wang, P Aliahmad, C Maine, HL Davis, C Pace US Patent App. 17/370,337, 2022 | 3 | 2022 |
| Rna replicon encoding a stabilized corona virus spike protein J Dehart, C Maine, BS Marro, JPM Langedijk, L Rutten, R Vogels, ... | 1 | 2021 |
| Integrating context of tumor biology and vaccine design to shape multidimensional immunotherapies NS Wang, CJ Maine Future Drug Discovery 2 (1), FDD25, 2020 | 1 | 2020 |
| Abstract PO3-26-06: A self-replicating RNA Precision Immunotherapeutic for Overcoming Resistance to Endocrine Therapy in Estrogen Receptor Positive Breast Cancer (ER+ BC) Z Goldberg, C Maine, G Dailey, C Domingo, G Picarda, H Little, A Chou, ... Cancer Research 84 (9_Supplement), PO3-26-06-PO3-26-06, 2024 | | 2024 |
| 876 Self-replicating RNA therapeutics for off-the-shelf precision immunotherapy targeting acquired resistance mutations in low TMB tumors Z Goldberg, C Maine, GP Dailey, C Domingo, G Picarda, H Little, A Chou, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| A self-replicating RNA precision medicine approach to therapeutic protein delivery of narrow therapeutic index biomolecules Z Goldberg, C Maine, GP Dailey, C Domingo, G Picarda, H Little, A Chou, ... Cancer Research 83 (7_Supplement), 2732-2732, 2023 | | 2023 |
| A self-replicating RNA precision medicine approach to overcoming resistance to endocrine therapy in ER+ BC Z Goldberg, C Maine, GP Dailey, C Domingo, G Picarda, H Little, A Chou, ... Cancer Research 83 (7_Supplement), 6403-6403, 2023 | | 2023 |
| SARS-CoV-2 Vaccines J DeHart, C Maine, BS Marro, JPM Langedijk, L Rutten, MJG Bakkers, ... US Patent App. 17/317,279, 2021 | | 2021 |
